Report Detail
Global Personalized Medicine and Epigenomics Market Growth (Status and Outlook) 2019-2024
- RnM3145472 |
- 19 March, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Other
Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
According to this study, over the next five years the Personalized Medicine and Epigenomics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Personalized Medicine and Epigenomics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Personalized Medicine and Epigenomics market by product type, application, key companies and key regions.
This study considers the Personalized Medicine and Epigenomics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Reagents
Kits
Enzymes
Services
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Oncology
Non-Oncology
Cancer Drug Technology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Personalized Medicine and Epigenomics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Personalized Medicine and Epigenomics market by identifying its various subsegments.
Focuses on the key global Personalized Medicine and Epigenomics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Personalized Medicine and Epigenomics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Personalized Medicine and Epigenomics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Personalized Medicine and Epigenomics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Personalized Medicine and Epigenomics Market Size 2014-2024
- 2.1.2 Personalized Medicine and Epigenomics Market Size CAGR by Region
- 2.2 Personalized Medicine and Epigenomics Segment by Type
- 2.2.1 Reagents
- 2.2.2 Kits
- 2.2.3 Instruments
- 2.2.4 Enzymes
- 2.2.5 Services
- 2.3 Personalized Medicine and Epigenomics Market Size by Type
- 2.3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type (2014-2019)
- 2.4 Personalized Medicine and Epigenomics Segment by Application
- 2.4.1 Oncology
- 2.4.2 Non-Oncology
- 2.4.3 Cancer Drug Technology
- 2.5 Personalized Medicine and Epigenomics Market Size by Application
- 2.5.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Application (2014-2019)
3 Global Personalized Medicine and Epigenomics by Players
- 3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Players
- 3.1.1 Global Personalized Medicine and Epigenomics Market Size by Players (2017-2019)
- 3.1.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Players (2017-2019)
- 3.2 Global Personalized Medicine and Epigenomics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Personalized Medicine and Epigenomics by Regions
- 4.1 Personalized Medicine and Epigenomics Market Size by Regions
- 4.2 Americas Personalized Medicine and Epigenomics Market Size Growth
- 4.3 APAC Personalized Medicine and Epigenomics Market Size Growth
- 4.4 Europe Personalized Medicine and Epigenomics Market Size Growth
- 4.5 Middle East & Africa Personalized Medicine and Epigenomics Market Size Growth
5 Americas
- 5.1 Americas Personalized Medicine and Epigenomics Market Size by Countries
- 5.2 Americas Personalized Medicine and Epigenomics Market Size by Type
- 5.3 Americas Personalized Medicine and Epigenomics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Personalized Medicine and Epigenomics Market Size by Countries
- 6.2 APAC Personalized Medicine and Epigenomics Market Size by Type
- 6.3 APAC Personalized Medicine and Epigenomics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Personalized Medicine and Epigenomics by Countries
- 7.2 Europe Personalized Medicine and Epigenomics Market Size by Type
- 7.3 Europe Personalized Medicine and Epigenomics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Personalized Medicine and Epigenomics by Countries
- 8.2 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type
- 8.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Personalized Medicine and Epigenomics Market Forecast
- 10.1 Global Personalized Medicine and Epigenomics Market Size Forecast (2019-2024)
- 10.2 Global Personalized Medicine and Epigenomics Forecast by Regions
- 10.2.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Personalized Medicine and Epigenomics Forecast by Type
- 10.8 Global Personalized Medicine and Epigenomics Forecast by Application
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Company Details
- 11.1.2 Personalized Medicine and Epigenomics Product Offered
- 11.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbott Laboratories News
- 11.2 Affymetrix
- 11.2.1 Company Details
- 11.2.2 Personalized Medicine and Epigenomics Product Offered
- 11.2.3 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Affymetrix News
- 11.3 Agilent Technologies
- 11.3.1 Company Details
- 11.3.2 Personalized Medicine and Epigenomics Product Offered
- 11.3.3 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Agilent Technologies News
- 11.4 Astellas Pharmaceuticals
- 11.4.1 Company Details
- 11.4.2 Personalized Medicine and Epigenomics Product Offered
- 11.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Astellas Pharmaceuticals News
- 11.5 BAYER AG
- 11.5.1 Company Details
- 11.5.2 Personalized Medicine and Epigenomics Product Offered
- 11.5.3 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 BAYER AG News
- 11.6 Bio Vision
- 11.6.1 Company Details
- 11.6.2 Personalized Medicine and Epigenomics Product Offered
- 11.6.3 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Bio Vision News
- 11.7 Celgene Corp.
- 11.7.1 Company Details
- 11.7.2 Personalized Medicine and Epigenomics Product Offered
- 11.7.3 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Celgene Corp. News
- 11.8 Emd Millipore
- 11.8.1 Company Details
- 11.8.2 Personalized Medicine and Epigenomics Product Offered
- 11.8.3 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Emd Millipore News
- 11.9 Epigenomics AG
- 11.9.1 Company Details
- 11.9.2 Personalized Medicine and Epigenomics Product Offered
- 11.9.3 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Epigenomics AG News
- 11.10 Epigentex
- 11.10.1 Company Details
- 11.10.2 Personalized Medicine and Epigenomics Product Offered
- 11.10.3 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Epigentex News
- 11.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
- 11.12 Gilead Sciences
- 11.13 Glaxosmithkline
- 11.14 Illumina Inc.
- 11.15 Johnson & Johnson
- 11.16 Karus Therapeutics Limited
- 11.17 Laboratory Corp. Of America Holdings
- 11.18 LES Laboratoires Servier
- 11.19 Merck
- 11.20 Naturewise Biotech & Medicals Corp.
- 11.21 Novartis Pharma AG
- 11.22 Oncolys Biopharma Inc.
- 11.23 Orchid Chemicals & Pharmaceuticals Limited
- 11.24 Progen Pharmaceuticals Limited
- 11.25 Quest Diagnostics
- 11.26 Roche Holding AG
- 11.27 Rubicon Genomics
- 11.28 Takeda Pharmaceutical Company Limited
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Personalized Medicine and Epigenomics . Industry analysis & Market Report on Personalized Medicine and Epigenomics is a syndicated market report, published as Global Personalized Medicine and Epigenomics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Personalized Medicine and Epigenomics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
